A5293812
Lisinopril Dihydrate , ≥98% , 83915-83-7
Synonym(s):
(S)-1-[N2-(1-carboxy-3-phenylpropyl)-lysyl-proline dihydrate;Lisinopril;MK-521
CAS NO.:83915-83-7
Empirical Formula: C21H31N3O5
Molecular Weight: 405.49
MDL number: MFCD08064198
EINECS: 627-033-9
Pack Size | Price | Stock | Quantity |
1G | RMB31.20 | In Stock |
|
5G | RMB79.20 | In Stock |
|
25g | RMB319.20 | In Stock |
|
100g | RMB1012.80 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 148 °C |
alpha | 25405 -120° (c = 1 in 0.25M pH 6.4 zinc acetate); 25436 -96° (c = 1 in 0.25M pH 6.4 zinc acetate) |
refractive index | -45 ° (C=1, 0.25mol/L Zinc Acetate Buffer) |
storage temp. | 2-8°C |
solubility | H2O: ≥10 mg/mL |
pka | 2.5, 4.0, 6.7, 10.1(at 25℃) |
form | solid |
color | white |
Water Solubility | H2O: ≥10mg/mL DMSO: ~6.5mg/mL (with heating and sonicating) |
Merck | 14,5516 |
Stability: | Hygroscopic |
CAS DataBase Reference | 83915-83-7(CAS DataBase Reference) |
EPA Substance Registry System | L-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-, hydrate (1:2) (83915-83-7) |
Description and Uses
Lisinopril is an angiotensin converting enzyme inhibitor structurally related to enalaprilat. It is reportedly useful in the management of hypertension and congestive heart failure.
An orally active angiotensin-converting enzyme (ACE) inhibitor. S,S,S-Isomer of Lisinopril.
Safety
Symbol(GHS) | ![]() GHS08 |
Signal word | Danger |
Hazard statements | H360D-H373 |
Precautionary statements | P202-P260-P280-P308+P313-P405-P501 |
Hazard Codes | Xi,Xn |
Risk Statements | 20/21/22 |
Safety Statements | 22-24/25-36 |
WGK Germany | 3 |
RTECS | TW3589990 |
HazardClass | IRRITANT |
HS Code | 2933995300 |